Clinical Trial Update: Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pemetrexed/cisplatin versus gemcitabine/cisplatin in non-small cell lung cancer, with analysis by thymidylate synthase expression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed) (pemetrexed)
• Gemzar (gemcitabine) (gemcitabine)
• Platinol (Cisplatin) (Cisplatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN